- Home
- HBAN vs DGX Comparison
HBAN vs DGX Comparison
Compare HBAN & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBAN
- DGX
- Stock Information
- Founded
- HBAN 1866
- DGX 1967
- Country
- HBAN United States
- DGX United States
- Employees
- HBAN N/A
- DGX N/A
- Industry
- HBAN Major Banks
- DGX Medical Specialities
- Sector
- HBAN Finance
- DGX Health Care
- Exchange
- HBAN Nasdaq
- DGX Nasdaq
- Market Cap
- HBAN 21.9B
- DGX 19.2B
- IPO Year
- HBAN N/A
- DGX 1996
- Fundamental
- Price
- HBAN $14.79
- DGX $167.31
- Analyst Decision
- HBAN Buy
- DGX Buy
- Analyst Count
- HBAN 20
- DGX 13
- Target Price
- HBAN $18.18
- DGX $178.38
- AVG Volume (30 Days)
- HBAN 26.3M
- DGX 1.2M
- Earning Date
- HBAN 04-17-2025
- DGX 04-22-2025
- Dividend Yield
- HBAN 4.19%
- DGX 1.91%
- EPS Growth
- HBAN N/A
- DGX 2.67
- EPS
- HBAN 1.22
- DGX 7.69
- Revenue
- HBAN $6,947,000,000.00
- DGX $9,872,000,000.00
- Revenue This Year
- HBAN $15.70
- DGX $10.28
- Revenue Next Year
- HBAN $6.26
- DGX $3.84
- P/E Ratio
- HBAN $12.12
- DGX $21.76
- Revenue Growth
- HBAN 0.03
- DGX 6.70
- 52 Week Low
- HBAN $12.05
- DGX $125.42
- 52 Week High
- HBAN $18.45
- DGX $178.87
- Technical
- Relative Strength Index (RSI)
- HBAN 38.83
- DGX 47.83
- Support Level
- HBAN $14.74
- DGX $164.61
- Resistance Level
- HBAN $15.55
- DGX $168.14
- Average True Range (ATR)
- HBAN 0.35
- DGX 3.50
- MACD
- HBAN 0.08
- DGX -0.78
- Stochastic Oscillator
- HBAN 41.98
- DGX 36.28
About HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.